期刊文献+

美国《拜杜法案》介入权改革及其对中国的启示 被引量:12

Reforms of the Bayh-Dole Act's March-in Right and the Revelation for China
下载PDF
导出
摘要 美国1980年颁布的《拜杜法案》赋予政府机构强制项目承担者向第三方授权或许可发明专利的权力,即介入权。自法案颁布以来,有五个介入权申请的典型案例,但均未成功。为保障政府资助发明在商业化中的公众利益,美国学者认为,需要通过立法改革来平衡介入权的体系设计。这些改革措施包括:设置申诉程序;规定被许可者付出"最大努力"并定期报告;明确《拜杜法案》中的"合理条件";通过公开招标强制许可发明专利。本文借鉴美国介入权立法和改革经验,以期对中国《科技进步法》的进一步完善提供新思路。 The Bayh-Dole Act of 1980 in the United Sates grants federal agencies the power to force the recipients of federal research funding to license the resulting inventions to third parties. There have been five significant march-in petitions since the Bayh-Dole Act was implemented, but each petition was failed. American scholars believe that a few reforms to the system could help balance the march- in system's design and protect the public interest. Reforms include instituting an appeal process, mandating a duty of "best efforts" to commercialize subject inventions and report on those efforts, clarifying the meaning of the Bayh-Dole act's "reasonable terms" require- ment, and mandating auctions for licenses on subject inventions. This article drew lessons from the experience of legislation and reform of the Bayh-Dole march-in rights to provide new ideas for the further improvement of China's Science and Technology Law.
出处 《中国科技论坛》 CSSCI 北大核心 2017年第7期169-175,共7页 Forum on Science and Technology in China
基金 四川省知识产权教育与培训(交大)基地"高校知识产权法律保护研究"(IP0115012)
关键词 拜杜法案 介入权 公众利益 The Bayh-Dole Act March-in rights Public interest
  • 相关文献

参考文献2

二级参考文献12

  • 1House Committee on the Judiciary, Proposed Revisionand Amendment of the Patent Laws: Preliminary Draft, 81st Cong., 2d Sess., 91 (Comm. Print 1950).
  • 2刘静怡,阙光威.知识经济时代的创新机制-科技研发、政府资金与智慧财产权[A].知识经济与法制改造研讨会专辑(自版,元照总经销)[C].台湾法学会,2002.
  • 3Peter Arno, Michael Davis, Why Don' t We Enforce Existing Drug Price Control? The Unrecognized and Unenforced Reasonable Pricing Requirements Imposed upon Patents Deriving in whole or in part from Federally Funded Research, 75 TULANEL. REV. 651( 2001 ).
  • 4Birch Bayh and Robert Dole, Our Law Helps Patents Get New Drugs Sooner, WASHINGTON POST, April 11, 2002, at A28.
  • 5Barbara M. McGarey and Annette C. Levey ,Patents, Products, and Public Health: An Analysis of the CellPro March-In Petition. 14 Berkeley Tech. L.J. PETER MIKHAIL, Hopkins v. CellPro: An Illustration That Payenting and Exclusive Licensing of Fundmental Sceience is not Always in the Public Health, HAVARD JOURNAL OF LAW & TECHNOLOGY 13:2 at 384-386( 2000 winter).
  • 6Essential Inventions, Inc., Petition to Use Authority Un- der Bayh-Dole Act to Promote Access to Ritonavir, Jan. 29, 2004.p7. http://www.essentialinventions.org/legal/ norvir/norvir-29jan04petition.pdf.
  • 7Essential Inventions, Inc., Petition to Use Authority Un- der Bayh-Dole Act to Promote Access to Ritonavir, Jan. 29, 2004.p6. http://www.essentialinventions.org/legal/ norvir/norvir-29j anO4petition.pdf.
  • 8Testimony of Robert Weissman "The Role of Federally- Funded University Research in the Patent System" Be- fore theCommittee on the Judiciary U.S. SenateOctober 24, 2007. http://www.essentialaction.org/access/uplo- ads/weissman.judiciary. 10-24-2007.rtf.
  • 9William O'Brien. March-in Rights Under the Bayh- Dole Act: The NIH's Paper Tiger?, 43 Seton Hall L. Rev. 1403.
  • 10DAVID HALPERIN, The Bayh-Dole Act and March- In Rights, http://www.ott.nih.gov/.../David-Halperin- Attorney-Counselor, at 1-2: 17-18( 2001/05 ).

共引文献5

同被引文献184

引证文献12

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部